Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Codexis Inc. - news published 272 - readings 4.794

BACK

Codexis Inc.

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 28, 2025, the Board of Directors (the "Board") of Codexis, Inc. (the "Company"), upon the recommendation of the Board's Nominating and Corporate Governance Committee, appointed Cynthia Collin ...

31.03.2025

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSIO ...

24.03.2025

Codexis Inc.

Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services

Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services March 24, 2025 7:00 am EDT Download as PDF Represents first project to enter the ECO Synthesis™ Innovation Lab Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain RE ...

24.03.2025

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

14.03.2025

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

10.03.2025

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

06.03.2025

Codexis Inc.

Corporate Presentation March 2025

Corporate Presentation March 2025 Codexis: We Make Enzymes Make Drugs Foundational CodeEvolver® Directed Evolution Platform Enables More Efficient and Scalable Therapeutics Manufacturing Revenue Generating Pharma BioCatalysis Solutions Foundational business in small molecule manufacturing and other customized applications Increasingly positive cash contribution driven by ramp ...

06.03.2025

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

04.03.2025

Codexis Inc.

Presentation PDF FY 2024

Q4 & FY'2024 Results February 27, 2025 2024: Strengthened Fundamentals 1 2 Returned Pharma Biocatalysis business to a healthy growth trajectory Reduced costs, strengthened balance sheet & defined a path to profitability Sets the stage to realize the value of the ECO Synthesis platform and toolbox 2 Provided February 27, 2025, as part of an oral presentation and is qual ...

27.02.2025

Codexis Inc.

Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results February 27, 2025 4:05 pm EST Download as PDF Related Documents Earnings Webcast Audio Presentation PDF Total revenue of $59.3 million for the fiscal year ended December 31, 2024 Expect double digit growth for total revenue in 2025 2025 to demonstrate acceleration of commercial growth through double-stranded ...

27.02.2025

Codexis Inc.

Codexis to Participate in TD Cowen 45th Annual Health Care Conference

Codexis to Participate in TD Cowen 45th Annual Health Care Conference February 18, 2025 4:05 pm EST Download as PDF REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the TD Cowen 45 th Annual Health Care Co ...

18.02.2025

Codexis Inc.

Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th

Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th February 13, 2025 4:05 pm EST Download as PDF REDWOOD CITY, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report its financial results for ...

13.02.2025

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

13.02.2025

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

08.02.2025

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

08.02.2025

Codexis Inc. - news published 272 - readings 4.794

Codexis Inc.

Management Change/Compensation (Form 8-K)

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Codexis Inc.

Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Codexis Inc.

Corporate Presentation March 2025

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Codexis Inc.

Presentation PDF FY 2024

Codexis Inc.

Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Codexis Inc.

Codexis to Participate in TD Cowen 45th Annual Health Care Conference

Codexis Inc.

Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Codexis Inc.

Statement of Changes in Beneficial Ownership (Form 4)

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member